December 2013.
All items were approved in accordance with the Notice calling the EGM.
Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") from 28 June 2026 regarding the successful placing of a private placement of new Ordinary Shares in the...
Read MoreChristoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today, 17 September 2026, bought 2,500,000 shares in HBC in an off-market transaction at an...
Read More